MedPath

Evaluation of the efficacy of atorvastatin mouthwash 1% in prevention of radiotherapy induced oral mucositis.

Phase 2
Conditions
Oral mucositis.
??????? ????? ( ??? ????? )
Registration Number
IRCT201502033014N9
Lead Sponsor
Vice chancellor for research, Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Cancer patients between 18-70 years receiving 5-fluorouracil containing chemotherapy regimens. Exclusion criteria: Sucralfate intolerance or inappropriate use of the mouth wash

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oral mucositis. Timepoint: Every 3 days. Method of measurement: Use of the WHO table and ruler.
Secondary Outcome Measures
NameTimeMethod
Pain. Timepoint: After 1 month of intervention. Method of measurement: Quastionnaire.
© Copyright 2025. All Rights Reserved by MedPath